Development of Novel Clinical Endpoints in Intermediate AMD

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Development of Novel Clinical Endpoints in Intermediate AMD	eye disorder, macular degeneration, retinal degeneration, retinal disorder	Active, not recruiting	Not stated	2025-01-16		NCT03349801

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Association for Innovation and Biomedical Research on Light and Image	9
Bayer	178
Carl Zeiss Meditec AG	9
City, University of London	6
European Clinical Research Infrastructure Network	6
Frank G. Holz	1
Hoffmann-La Roche	280
Innovative Medicines Initiative	6
La Fondation Voir et Entendre	1
Moorfields Eye Hospital NHS Foundation Trust	11
Novartis Pharmaceuticals	432
Radboud University Medical Center	216
University College, London	222
University of Sheffield	43

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre d'Investigation Clinique Centre National d'Ophtalmologie des Quinze-Vingts	Paris	France	1
Centre for Clinical Trials, AIBILI	Coimbra	Portugal	1
Centre Hospitalier Intercommunal De Creteil	Créteil	France	3
Centro Hospitalar de São João, E.P.E.	Porto	Portugal	1
Department of Ophthalmology, University of Freiburg	Freiburg im Breisgau	Germany	1
G.B.Bietti Eye Foundation	Rome	Italy	1
Gloucestershire Hospitals NHS Foundation Trust	Gloucester	United Kingdom	1
Luigi Sacco Hospital	Milan	Italy	1
Moorfields Eye Hospital	London	United Kingdom	6
Ospedale San Raffaele	Milan	Italy	22
Queen's University Belfast	Belfast	United Kingdom	3
Radboud University Medical Centre	Nijmegen	Netherlands	8
Radboud University Medical Centre	Leiden	Netherlands	1
Righospitalet Copenhagen	Copenhagen	Denmark	1
St. Franziskus Hospital	Münster	Germany	4
University Eye Hospital Munich	Munich	Germany	1
University Eye Hospital Ulm	Ulm	Germany	2
University Hospital Bonn	Bonn	Germany	13
University Hospital Cologne	Cologne	Germany	14
Universtiy Hospital Tuebingen	Tübingen	Germany	1

Clinical trials